|
| |
marinus pharmaceuticals Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
BioSpace - Marinus Pharmaceuticals News, Search Jobs, Events
Marinus Pharmaceuticals Completes Two Phase 2 Milestones for Ganaxolone in Epilepsy Marinus Closes Phase 2 Trials for Infantile Spasms and Completes ...
http://www.biospace.com/company_profile.aspx?CompanyId=10032...
|
BioPortfolio - Marinus Pharmaceuticals
Marinus Pharmaceuticals - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/26002-Marinus_Pharm...
|
Marinus Pharmaceuticals Raises $29.4 Million - News, Search ...
25 Oct 2005 ... Marinus Pharmaceuticals, Inc. is based in Branford, CT and is dedicated to the identification, development and commercialization of drugs to ...
http://www.biospace.com/news_story.aspx?StoryID=381...
|
University of Tennessee Health Science Center: College of Medicine
Marinus Pharmaceuticals, (Protocol 1042-0500) A Double-Blind, Placebo-Controlled Dose Ranging Clinical Study to Evaluate the Safety, Tolerability and ...
http://www.utmem.edu/neurology/home.php?doc=perkins.htm...
|
Marinus Pharmaceuticals Completes Two Phase 2 Milestones for ...
BRANFORD, Conn., Oct. 7 /PRNewswire/ -- Marinus Pharmaceuticals, a developer of specialty therapeutics to treat neurological and psychiatric disorders, ...
http://www.biospace.com/news_story.aspx?NewsEntityId=112171...
|
University of Tennessee Health Science Center: College of Medicine
Marinus Pharmaceuticals, (Protocol 1042-0501), An Open-label Clinical Study to evaluate the safety, tolerability, and and antiepileptic activity of ...
http://www.utmem.edu/neurology/home.php?doc=clarke.htm...
|
Marinus Pharmaceuticals Initiates Phase IIb Study of Ganaxolone ...
28 /PRNewswire/ -- Marinus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on novel drugs to treat serious neurological disorders, ...
http://www.biospace.com/news_story.aspx?NewsEntityId=47448...
|
People : Article : Nature Biotechnology
Marinus Pharmaceuticals (Branford, CT, USA) has appointed John Krayacich as president and CEO. Krayacich brings more than 20 years of experience in ...
http://www.nature.com/nbt/journal/v26/n9/full/nbt0908-1050.h...
|
Marinus Pharmaceuticals Initiates Phase IIb Study of Ganaxolone ...
BRANFORD, Conn., May 4 /PRNewswire/ -- Marinus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on novel drugs to treat serious ...
http://www.biospace.com/news_story.aspx?NewsEntityId=54983...
|
Yale University Office of Cooperative Research
Marinus Pharmaceuticals Inc., a Bradford, Conn.-based drug company focused on neurological and psychiatric disorders, has raised $28.14 million in Series A
...
http://www.yale.edu/ocr/news/archive-ct-05.html...
|
|
